Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Dermatology : EJD|July 9, 2010
Bullous dermatosis associated with IgG antibodies specific for desmocollinsYuichiro Endo, Kaoru Tsujioka, Miki Tanioka, et al.
Expert Opinion on Therapeutic Targets|January 9, 2013
Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgarisHiroshi Koga, Daisuke Tsuruta, Bungo Ohyama, et al.
The Journal of Dermatology|July 16, 2010
Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexistJunko Shiohara, Kanako Yoshida, Junichi Hasegawa, et al.
European Journal of Dermatology : EJD|April 30, 2014
Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceusAgustín España, Hiroshi Koga, Ricardo Suárez-Fernández, et al.
JAMA Dermatology|August 16, 2013
Two cases of pemphigus vegetans with IgG anti-desmocollin 3 antibodiesHiroshi Saruta, Norito Ishii, Kwesi Teye, et al.
Dermatologic Therapy|October 10, 2013
Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularisTakako Shintani, Chika Ohata, Hiroshi Koga, et al.
Dermatologic Therapy|September 7, 2012
Therapeutic effect of mizoribine on pemphigus vulgaris and pemphigus foliaceusTakashi Hashimoto, Tamihiro Kawakami, Hiroshi Koga, et al.
Dermatologic Therapy|June 30, 2012
Oral zinc therapy for zinc deficiency-related telogen effluviumTadashi Karashima, Daisuke Tsuruta, Takahiro Hamada, et al.
Journal of the American Academy of Dermatology|August 15, 2009
A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicineNoriko Tanaka, Teruki Dainichi, Bungo Ohyama, et al.
Pageof 4